In the positive control group, there was no CD133 expression in the GIST cells (Fig. 1D), while CD133 was positively expressed in the gastric cancer and brain glioma cells (Fig. 1E and F). This evidence concerns the gene PROM1 and gastrointestinal stromal tumor.